Opportunities for Healthy Volunteers
Contribute to medical research by participating in studies designed for healthy participants in your selected area.
↓
Matched clinical trials
Study Comparing Axicabtagene Ciloleucel with Standard Treatment for Patients with Relapsed or Refractory Follicular Lymphoma
Not recruiting
Investigated Diseases:Investigated Drugs:
Study of capivasertib tablets in patients with relapsed or refractory B-cell non-Hodgkin lymphoma
Not recruiting
Investigated Diseases:Investigated Drugs:
Study of Rapcabtagene Autoleucel and Ibrutinib for Adults with Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, and Other Blood Cancers
Not recruiting
Investigated Diseases:Investigated Drugs:
Long-Term Access to Ibrutinib for Patients with Lymphoma, Leukemia, and Other Conditions
Not recruiting
Investigated Drugs:
+1
Study on MB-CART19.1 for Patients with Relapsed or Refractory CD19 Positive B Cell Malignancies
Not recruiting
Investigated Diseases:Investigated Drugs:
Study of Mosunetuzumab and Zanubrutinib for Patients with Relapsed or Refractory Follicular Lymphoma
Not recruiting
Investigated Diseases:Investigated Drugs:
Study of Tazemetostat with R-CHOP for Newly Diagnosed Diffuse Large B Cell Lymphoma or High-Risk Follicular Lymphoma Patients
Not recruiting
Investigated Diseases:Investigated Drugs:
Study on Mosunetuzumab and Lenalidomide for Patients with Follicular Lymphoma After Previous Treatment
Not recruiting
Investigated Diseases:
Study on the Effectiveness and Safety of Tisagenlecleucel for Adults with Hard-to-Treat or Returning Follicular Lymphoma
Not recruiting
Investigated Drugs:
+1
